US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ODDITY Tech Ltd.

16.44

-0.0400-0.24%

Volume:1.56M

Turnover:25.43M

Market Cap:758.29M

PE:20.81

High:17.28

Open:16.60

Low:15.45

Close:16.48

52wk High:64.23

52wk Low:9.25

Shares:46.12M

Float Shares:28.59M

Volume Ratio:0.53

T/O Rate:5.45%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.7900

EPS(LYR):1.80

ROE:5.10%

ROA:-0.48%

PB:3.12

PE(LYR):9.13

Loading ...

Overview Company News Filings

Creating a Sustainable Impact: Fosun International Releases 2025 ESG Report and Climate Information Disclosures Report

Intellia Therapeutics Reports Positive Phase 3 Results in Hereditary Angioedema, Marking a Global First for In Vivo Gene Editing

Oddity Tech faces shareholder class action over alleged advertising cost disclosure omissions

Radiopharm Theranostics Reports Business Update

Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Opamtistomig (LBL-024) Enters Phase Ⅱ Trial with First Patient Dosing in Gastric Cancer, Pioneering Enhanced Immunotherapy Combination Strategies

Medicus Pharma submits ODD application to U.S. FDA for SkinJect

ASX Runners of the Week: Bison, Genetic Signatures, Narryer & Immutep

The West Australian

Oddity Tech faces securities class action over alleged misleading ad efficiency disclosures

A Look At Oddity Tech (ODD) Valuation As Securities Class Action Raises Questions On Customer Acquisition Costs

Simply Wall St.

Immix Biopharma to Participate in the Jefferies Global Healthcare Conference

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Advances to Expansion Phase in First-Line Biliary Tract Cancer Following Positive Safety and Preliminary Efficacy Results

Plus Therapeutics Granted U.S. FDA Orphan Drug Designation to REYOBIQ™ in Pediatric Malignant Gliomas

Kodiak AI Expands Autonomous Trucking Beyond the Sunbelt with Demonstrations in Ohio and Indiana

Oddity Tech (ODD) Faces Investor Lawsuit Over Alleged Ad Algorithm Disclosures

Immix Biopharma Announces Enrollment Completion of BLA-Enabling Relapsed/Refractory AL Amyloidosis Trial NEXICART-2, and Upcoming Milestones

Press Release: Unicycive Therapeutics Announces Full Year 2025 Financial Results and Provides Business Update

ODDITY Tech Is Maintained at Neutral by Goldman Sachs

Oddity Tech Faces Securities Lawsuit After Stock Drops Nearly 50% on Advertising Disruption Disclosure

Oddity Tech director Michael Farello files initial beneficial ownership statement

Key Corporate Announcements Summary for March 24 Evening

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/ODD/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ODD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ODD\",,,,,undefined,":{"symbol":"ODD","market":"US","secType":"STK","nameCN":"ODDITY Tech Ltd.","latestPrice":16.44,"timestamp":1789069515214,"preClose":16.48,"halted":0,"volume":1559364,"delay":0,"changeRate":-0.0024271844660193657,"floatShares":28586000,"shares":46124600,"eps":0.79,"marketStatus":"Trading","change":-0.04,"latestTime":"09-10 15:45:19 EDT","open":16.6,"high":17.28,"low":15.45,"amount":25427572.586136002,"amplitude":0.111044,"askPrice":16.49,"askSize":4,"bidPrice":16.43,"bidSize":183,"shortable":3,"etf":0,"ttmEps":0.79,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789070400000},"marketStatusCode":2,"adr":0,"listingDate":1689739200000,"exchange":"NASDAQ","adjPreClose":16.48,"preHourTrading":{"tag":"盘前","latestPrice":16.59,"preClose":16.48,"latestTime":"09:29 EDT","volume":18679,"amount":306164.929977,"timestamp":1789046999999,"change":0.11,"changeRate":0.006675,"amplitude":0.05182},"postHourTrading":{"tag":"盘后","latestPrice":16.5542,"preClose":16.48,"latestTime":"19:59 EDT","volume":67608,"amount":1121352.8622,"timestamp":1788998388126,"change":0.0742,"changeRate":0.004502,"amplitude":0.043083},"volumeRatio":0.530371,"impliedVol":0.9315,"impliedVolPercentile":0.51},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ODD\",,,,,undefined,":{"symbol":"ODD","floatShares":28586000,"roa":"-0.48%","roe":"5.10%","lyrEps":1.8,"volumeRatio":0.530371,"shares":46124600,"dividePrice":0,"high":17.28,"amplitude":0.111044,"preClose":16.48,"low":15.45,"week52Low":9.2501,"pbRate":"3.12","psRate":"1.12","week52High":64.23,"institutionHeld":0,"latestPrice":16.44,"committee":0.957219,"eps":0.79,"divideRate":0,"volume":1559364,"delay":0,"ttmEps":0.79,"open":16.6,"prevYearClose":40.18,"prevWeekClose":13.75,"prevMonthClose":14.4,"prevQuarterClose":15.13,"fiveDayClose":14.49,"twentyDayClose":12.9,"sixtyDayClose":11.56},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ODD\",params:#limit:5,,,undefined,":[{"date":"2026-09-09","symbol":"ODD","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2026/06","expectedEps":0,"defaultRemindTime":1788940800000,"name":null,"time":"Pre-MKt","dateTimestamp":1788926400000,"actualEps":null},{"market":"US","date":"2026-06-02","symbol":"ODD","fiscalQuarterEnding":"2026/03","expectedEps":-0.08,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1780372800000,"reportTimeType":"pre","actualEps":-0.29},{"market":"US","date":"2026-02-25","symbol":"ODD","fiscalQuarterEnding":"2025/12","expectedEps":0.04,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1771995600000,"reportTimeType":"pre","actualEps":0.1},{"market":"US","date":"2025-11-19","symbol":"ODD","fiscalQuarterEnding":"2025/09","expectedEps":0.24,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1763528400000,"reportTimeType":"post","actualEps":0.28},{"market":"US","date":"2025-08-04","symbol":"ODD","fiscalQuarterEnding":"2025/06","expectedEps":0.79,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754280000000,"reportTimeType":"post","actualEps":0.76}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ODD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ODD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":0.7,"sell":0.3,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.7,"analysts":10,"updateTime":1780545600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ODD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ODD","date":"2026-09-09","current":20.848101,"percent":0.842784,"low":6.104615,"twenty":18.46445,"median":26.645529,"eighty":37.346611,"high":144.174884,"avg":28.887528,"sd":16.651673,"marketCap":600772315},"quantilePoints":[{"date":"2023-07-21","current":130.121737,"twenty":124.979326,"median":126.90773,"eighty":128.836134,"marketCap":2827285100},{"date":"2023-07-28","current":127.857619,"twenty":126.192061,"median":128.560276,"eighty":129.606455,"marketCap":2778090339},{"date":"2023-08-04","current":144.174884,"twenty":128.138682,"median":130.121737,"eighty":138.668132,"marketCap":3132631890},{"date":"2023-08-11","current":59.921033,"twenty":128.138682,"median":131.59899,"eighty":138.150305,"marketCap":3096718967},{"date":"2023-08-18","current":49.805463,"twenty":52.028567,"median":129.262933,"eighty":135.506534,"marketCap":2573946329},{"date":"2023-08-25","current":45.155781,"twenty":48.598524,"median":91.807378,"eighty":132.13135,"marketCap":2333650744},{"date":"2023-09-01","current":45.716381,"twenty":47.266275,"median":50.709145,"eighty":131.711973,"marketCap":2362622552},{"date":"2023-09-08","current":40.286255,"twenty":46.134083,"median":49.805463,"eighty":131.410685,"marketCap":2081993665},{"date":"2023-09-15","current":40.648996,"twenty":43.649855,"median":48.206104,"eighty":130.121737,"marketCap":2100740129},{"date":"2023-09-22","current":30.701094,"twenty":40.692965,"median":47.574055,"eighty":129.262933,"marketCap":1586632553},{"date":"2023-09-29","current":31.151773,"twenty":36.878686,"median":46.562777,"eighty":127.857619,"marketCap":1609923614},{"date":"2023-10-06","current":28.491671,"twenty":32.503808,"median":45.749357,"eighty":123.693723,"marketCap":1472449544},{"date":"2023-10-13","current":31.976185,"twenty":32.503808,"median":44.402818,"eighty":59.921033,"marketCap":1652529215},{"date":"2023-10-20","current":29.832714,"twenty":31.459553,"median":41.803173,"eighty":57.306257,"marketCap":1541754654},{"date":"2023-10-27","current":29.832714,"twenty":31.15617,"median":40.714949,"eighty":54.667412,"marketCap":1541754654},{"date":"2023-11-03","current":29.678824,"twenty":30.355941,"median":40.467625,"eighty":50.479578,"marketCap":1533801609},{"date":"2023-11-10","current":30.298177,"twenty":30.305454,"median":36.878686,"eighty":50.003322,"marketCap":1598562121},{"date":"2023-11-17","current":37.221321,"twenty":30.355941,"median":36.411519,"eighty":49.783479,"marketCap":1963834134},{"date":"2023-11-24","current":37.016749,"twenty":30.445709,"median":37.119035,"eighty":49.462508,"marketCap":1953040715},{"date":"2023-12-01","current":36.693741,"twenty":30.5941,"median":37.016749,"eighty":48.26876,"marketCap":1935998475},{"date":"2023-12-08","current":40.591374,"twenty":30.734071,"median":37.17287,"eighty":48.041138,"marketCap":2141641505},{"date":"2023-12-15","current":46.060981,"twenty":30.923136,"median":37.910406,"eighty":47.753992,"marketCap":2430223438},{"date":"2023-12-22","current":50.712301,"twenty":31.153971,"median":38.59949,"eighty":48.041138,"marketCap":2675631695},{"date":"2023-12-29","current":50.884572,"twenty":31.160567,"median":38.868664,"eighty":49.761494,"marketCap":2684720890},{"date":"2024-01-05","current":46.7716,"twenty":31.28148,"median":39.765881,"eighty":49.183424,"marketCap":2467716366},{"date":"2024-01-12","current":46.965405,"twenty":31.46395,"median":40.526773,"eighty":48.323896,"marketCap":2477941710},{"date":"2024-01-19","current":45.899477,"twenty":31.472743,"median":40.645209,"eighty":48.306372,"marketCap":2421702318},{"date":"2024-01-26","current":45.684138,"twenty":31.580467,"median":40.703957,"eighty":48.306372,"marketCap":2410340824},{"date":"2024-02-02","current":45.156558,"twenty":31.989432,"median":42.12028,"eighty":48.252127,"marketCap":2382505165},{"date":"2024-02-09","current":48.246671,"twenty":32.113484,"median":43.346019,"eighty":48.217673,"marketCap":2545542596},{"date":"2024-02-16","current":46.125583,"twenty":32.418946,"median":44.467474,"eighty":48.217673,"marketCap":2433631886},{"date":"2024-02-23","current":42.389454,"twenty":32.503808,"median":43.451996,"eighty":48.101679,"marketCap":2236509975},{"date":"2024-03-01","current":45.414965,"twenty":32.586249,"median":43.346019,"eighty":47.880595,"marketCap":2396138958},{"date":"2024-03-08","current":42.187798,"twenty":32.646706,"median":43.451996,"eighty":47.880595,"marketCap":2469420590},{"date":"2024-03-15","current":43.718187,"twenty":32.976471,"median":43.684021,"eighty":47.798976,"marketCap":2559000375},{"date":"2024-03-22","current":43.038127,"twenty":33.910804,"median":43.451996,"eighty":47.751391,"marketCap":2519193702},{"date":"2024-03-28","current":41.755726,"twenty":34.121582,"median":43.229275,"eighty":47.682483,"marketCap":2444129691},{"date":"2024-04-05","current":35.33401,"twenty":34.429566,"median":43.074483,"eighty":47.592295,"marketCap":2068240969},{"date":"2024-04-12","current":35.168853,"twenty":35.003425,"median":42.938568,"eighty":47.491972,"marketCap":2058573635},{"date":"2024-04-19","current":32.672059,"twenty":33.859301,"median":42.736957,"eighty":47.44561,"marketCap":1912426280},{"date":"2024-04-26","current":30.816464,"twenty":32.666988,"median":42.389454,"eighty":47.239294,"marketCap":1803810931},{"date":"2024-05-03","current":32.701204,"twenty":32.521826,"median":42.280345,"eighty":47.139393,"marketCap":1914132280},{"date":"2024-05-10","current":30.051334,"twenty":32.188614,"median":42.12028,"eighty":47.109682,"marketCap":2161502316},{"date":"2024-05-17","current":34.470881,"twenty":32.029175,"median":41.880975,"eighty":47.036466,"marketCap":2479387030},{"date":"2024-05-24","current":28.991908,"twenty":31.962852,"median":41.668069,"eighty":46.979437,"marketCap":2085300972},{"date":"2024-05-31","current":28.39104,"twenty":31.618936,"median":40.692965,"eighty":46.967038,"marketCap":2042082299},{"date":"2024-06-07","current":35.032218,"twenty":31.466148,"median":40.618291,"eighty":46.952485,"marketCap":2519762369},{"date":"2024-06-14","current":31.434913,"twenty":31.466148,"median":40.526773,"eighty":46.846969,"marketCap":2261018998},{"date":"2024-06-21","current":31.17401,"twenty":31.40776,"median":40.286255,"eighty":46.77806,"marketCap":2242252995},{"date":"2024-06-28","current":31.039605,"twenty":31.15617,"median":39.116208,"eighty":46.676851,"marketCap":2232585660},{"date":"2024-07-05","current":32.549682,"twenty":31.153971,"median":38.825596,"eighty":46.51104,"marketCap":2341201009},{"date":"2024-07-12","current":33.300768,"twenty":31.165014,"median":38.233414,"eighty":46.411983,"marketCap":2395224351},{"date":"2024-07-19","current":31.719535,"twenty":31.193823,"median":37.851188,"eighty":46.379683,"marketCap":2281491001},{"date":"2024-07-26","current":32.889648,"twenty":31.177172,"median":37.124419,"eighty":46.315081,"marketCap":2365653680},{"date":"2024-08-02","current":30.43083,"twenty":31.177172,"median":37.016749,"eighty":46.269497,"marketCap":2188798320},{"date":"2024-08-09","current":24.621128,"twenty":31.077829,"median":36.878686,"eighty":46.15167,"marketCap":2152403648},{"date":"2024-08-16","current":25.909103,"twenty":30.914687,"median":36.319047,"eighty":46.132383,"marketCap":2264999665},{"date":"2024-08-23","current":24.744722,"twenty":30.826367,"median":35.664326,"eighty":46.112663,"marketCap":2163208317},{"date":"2024-08-30","current":23.938111,"twenty":30.576415,"median":35.479654,"eighty":46.043754,"marketCap":2092693640},{"date":"2024-09-06","current":21.999645,"twenty":30.415298,"median":35.251431,"eighty":45.974846,"marketCap":1923230948},{"date":"2024-09-13","current":22.858294,"twenty":30.138302,"median":35.032218,"eighty":45.974846,"marketCap":1998294959},{"date":"2024-09-20","current":23.144511,"twenty":29.832714,"median":34.577614,"eighty":45.899477,"marketCap":2023316296},{"date":"2024-09-27","current":25.837549,"twenty":29.733784,"median":34.493388,"eighty":45.749357,"marketCap":2258744331},{"date":"2024-10-04","current":26.907033,"twenty":29.206161,"median":34.203986,"eighty":45.716381,"marketCap":2352239691},{"date":"2024-10-11","current":26.632604,"twenty":28.857503,"median":34.05976,"eighty":45.700078,"marketCap":2328248903},{"date":"2024-10-18","current":26.737148,"twenty":28.675661,"median":33.782046,"eighty":45.684138,"marketCap":2337388251},{"date":"2024-10-25","current":24.829219,"twenty":28.39104,"median":33.498422,"eighty":45.587236,"marketCap":2170595150},{"date":"2024-11-01","current":24.874957,"twenty":27.774359,"median":33.138619,"eighty":45.414965,"marketCap":2174593614},{"date":"2024-11-08","current":25.903059,"twenty":26.907033,"median":32.701204,"eighty":45.328829,"marketCap":2624135294},{"date":"2024-11-15","current":22.412856,"twenty":26.554196,"median":32.64481,"eighty":45.156558,"marketCap":2270556768},{"date":"2024-11-22","current":25.688798,"twenty":26.266873,"median":32.549682,"eighty":45.155781,"marketCap":2602429343},{"date":"2024-11-29","current":26.196259,"twenty":26.231703,"median":32.526331,"eighty":45.078881,"marketCap":2653838175},{"date":"2024-12-06","current":27.019473,"twenty":26.102043,"median":32.510933,"eighty":44.930453,"marketCap":2737234726},{"date":"2024-12-13","current":27.882156,"twenty":26.129486,"median":32.397731,"eighty":44.829243,"marketCap":2824629741},{"date":"2024-12-20","current":24.673876,"twenty":26.102043,"median":32.284642,"eighty":44.80743,"marketCap":2499611678},{"date":"2024-12-27","current":24.555468,"twenty":26.074468,"median":32.122117,"eighty":44.68052,"marketCap":2487616283},{"date":"2025-01-03","current":24.036731,"twenty":26.028044,"median":31.982415,"eighty":44.572573,"marketCap":2435065032},{"date":"2025-01-10","current":24.916329,"twenty":25.91918,"median":31.969518,"eighty":44.533395,"marketCap":2524173675},{"date":"2025-01-17","current":25.299744,"twenty":25.850651,"median":31.948814,"eighty":44.510542,"marketCap":2563015904},{"date":"2025-01-24","current":24.983991,"twenty":25.688798,"median":31.719535,"eighty":44.467474,"marketCap":2531028186},{"date":"2025-01-31","current":26.906704,"twenty":25.660605,"median":31.631647,"eighty":44.252135,"marketCap":2725810541},{"date":"2025-02-07","current":24.025454,"twenty":25.660605,"median":31.600943,"eighty":44.067933,"marketCap":2433922614},{"date":"2025-02-14","current":24.245353,"twenty":25.528357,"median":31.476041,"eighty":43.718187,"marketCap":2456199775},{"date":"2025-02-21","current":24.809199,"twenty":25.393274,"median":31.447233,"eighty":43.663521,"marketCap":2513320700},{"date":"2025-02-28","current":26.194867,"twenty":25.287339,"median":31.363758,"eighty":43.611255,"marketCap":2658543217},{"date":"2025-03-07","current":24.561126,"twenty":25.149762,"median":31.267028,"eighty":43.481918,"marketCap":2492733193},{"date":"2025-03-14","current":25.259729,"twenty":25.127573,"median":31.17401,"eighty":43.282433,"marketCap":2563635122},{"date":"2025-03-21","current":23.829518,"twenty":25.089994,"median":31.105558,"eighty":43.231428,"marketCap":2418481566},{"date":"2025-03-28","current":23.620487,"twenty":25.062794,"median":30.968449,"eighty":43.177394,"marketCap":2397266815},{"date":"2025-04-04","current":20.886583,"twenty":24.97973,"median":30.909153,"eighty":43.121556,"marketCap":2119800209},{"date":"2025-04-11","current":22.872376,"twenty":24.935811,"median":30.865977,"eighty":43.052669,"marketCap":2321340339},{"date":"2025-04-17","current":23.075906,"twenty":24.876099,"median":30.80242,"eighty":42.991494,"marketCap":2341996807},{"date":"2025-04-25","current":24.341093,"twenty":24.812177,"median":30.590011,"eighty":42.947303,"marketCap":2470401876},{"date":"2025-05-02","current":33.211688,"twenty":24.800183,"median":30.612672,"eighty":42.912727,"marketCap":3531697688},{"date":"2025-05-09","current":37.275211,"twenty":24.812177,"median":30.809442,"eighty":42.852836,"marketCap":3963808661},{"date":"2025-05-16","current":33.075187,"twenty":24.823197,"median":30.881482,"eighty":42.719469,"marketCap":3517182333},{"date":"2025-05-23","current":36.009954,"twenty":24.840888,"median":30.917059,"eighty":42.57047,"marketCap":3829262479},{"date":"2025-05-30","current":37.968215,"twenty":24.859184,"median":31.004027,"eighty":42.466444,"marketCap":4037502005},{"date":"2025-06-06","current":40.472479,"twenty":24.875718,"median":31.151773,"eighty":42.376534,"marketCap":4303802953},{"date":"2025-06-13","current":38.84497,"twenty":24.888137,"median":31.181916,"eighty":42.353632,"marketCap":4130735251},{"date":"2025-06-20","current":36.618957,"twenty":24.907308,"median":31.267028,"eighty":42.321149,"marketCap":3894023297},{"date":"2025-06-27","current":37.637463,"twenty":24.9212,"median":31.363758,"eighty":42.207431,"marketCap":4002330181},{"date":"2025-07-03","current":39.798375,"twenty":24.940682,"median":31.434913,"eighty":42.187798,"marketCap":4232119427},{"date":"2025-07-11","current":38.424967,"twenty":24.946182,"median":31.476041,"eighty":42.12028,"marketCap":4086072618},{"date":"2025-07-18","current":37.17546,"twenty":24.957184,"median":31.58513,"eighty":42.056896,"marketCap":3953201285},{"date":"2025-07-25","current":36.450956,"twenty":24.962685,"median":31.617964,"eighty":41.958776,"marketCap":3876158244},{"date":"2025-08-01","current":36.786958,"twenty":24.983991,"median":31.719535,"eighty":41.803173,"marketCap":3911888350},{"date":"2025-08-08","current":29.269388,"twenty":24.988656,"median":31.680004,"eighty":41.755726,"marketCap":3223525522},{"date":"2025-08-15","current":29.576073,"twenty":25.039696,"median":31.613107,"eighty":41.668069,"marketCap":3257301638},{"date":"2025-08-22","current":30.491058,"twenty":25.068568,"median":31.584654,"eighty":40.714949,"marketCap":3358071703},{"date":"2025-08-29","current":30.947283,"twenty":25.079845,"median":31.470545,"eighty":40.692965,"marketCap":3408317165},{"date":"2025-09-05","current":31.494754,"twenty":25.083205,"median":31.459553,"eighty":40.65779,"marketCap":3468611719},{"date":"2025-09-12","current":31.935772,"twenty":25.085195,"median":31.488146,"eighty":40.645966,"marketCap":3517182333},{"date":"2025-09-19","current":31.793835,"twenty":25.089994,"median":31.584179,"eighty":40.616226,"marketCap":3501550411},{"date":"2025-09-26","current":29.994279,"twenty":25.105422,"median":31.49222,"eighty":40.594895,"marketCap":3303359978},{"date":"2025-10-03","current":30.739447,"twenty":25.114201,"median":31.481537,"eighty":40.590201,"marketCap":3385427566},{"date":"2025-10-10","current":26.927161,"twenty":25.127573,"median":31.451808,"eighty":40.571566,"marketCap":2965569012},{"date":"2025-10-17","current":26.01968,"twenty":25.135101,"median":31.389658,"eighty":40.56278,"marketCap":2865625373},{"date":"2025-10-24","current":24.575011,"twenty":25.135101,"median":31.29655,"eighty":40.533764,"marketCap":2706519695},{"date":"2025-10-31","current":22.697464,"twenty":25.089994,"median":31.260978,"eighty":40.483338,"marketCap":2499739752},{"date":"2025-11-07","current":20.840778,"twenty":25.062794,"median":31.168388,"eighty":40.3235,"marketCap":2295257365},{"date":"2025-11-14","current":21.127625,"twenty":24.961585,"median":31.125566,"eighty":40.286255,"marketCap":2326848745},{"date":"2025-11-21","current":20.632506,"twenty":24.914074,"median":31.026394,"eighty":40.195833,"marketCap":2272856204},{"date":"2025-11-28","current":22.556538,"twenty":24.864441,"median":30.973992,"eighty":40.067661,"marketCap":2484805645},{"date":"2025-12-05","current":23.453377,"twenty":24.800183,"median":30.947283,"eighty":39.942199,"marketCap":2583600507},{"date":"2025-12-12","current":23.171811,"twenty":24.744189,"median":30.91898,"eighty":39.889726,"marketCap":2552583516},{"date":"2025-12-19","current":22.108118,"twenty":24.698354,"median":30.913106,"eighty":39.830715,"marketCap":2435408215},{"date":"2025-12-26","current":21.97255,"twenty":24.603474,"median":30.881482,"eighty":39.790815,"marketCap":2420474108},{"date":"2026-01-02","current":20.950571,"twenty":24.5566,"median":30.865977,"eighty":39.747975,"marketCap":2307893917},{"date":"2026-01-09","current":20.079803,"twenty":24.511489,"median":30.793745,"eighty":39.569474,"marketCap":2211970999},{"date":"2026-01-16","current":18.426908,"twenty":24.453976,"median":30.739447,"eighty":39.33668,"marketCap":2029889771},{"date":"2026-01-23","current":18.270483,"twenty":24.345533,"median":30.673548,"eighty":39.245507,"marketCap":2012658109},{"date":"2026-01-30","current":17.535284,"twenty":24.313015,"median":30.590011,"eighty":39.075971,"marketCap":1931669298},{"date":"2026-02-06","current":15.001193,"twenty":24.204717,"median":30.513869,"eighty":38.986908,"marketCap":1652516376},{"date":"2026-02-13","current":14.396348,"twenty":24.048695,"median":30.485989,"eighty":38.976221,"marketCap":1585887283},{"date":"2026-02-20","current":15.950173,"twenty":23.978855,"median":30.423064,"eighty":38.890175,"marketCap":1757055125},{"date":"2026-02-27","current":7.139339,"twenty":23.850132,"median":30.333914,"eighty":38.866509,"marketCap":790646086},{"date":"2026-03-06","current":7.224918,"twenty":23.762072,"median":30.274296,"eighty":38.85757,"marketCap":800123500},{"date":"2026-03-13","current":6.950028,"twenty":23.706908,"median":30.138302,"eighty":38.84707,"marketCap":769680898},{"date":"2026-03-20","current":7.187922,"twenty":23.614586,"median":30.055287,"eighty":38.79877,"marketCap":796026424},{"date":"2026-03-27","current":6.865617,"twenty":23.526973,"median":29.994279,"eighty":38.783466,"marketCap":760332712},{"date":"2026-04-02","current":6.855385,"twenty":23.427349,"median":29.832714,"eighty":38.753843,"marketCap":759199579},{"date":"2026-04-10","current":7.072813,"twenty":23.171299,"median":29.799737,"eighty":38.548868,"marketCap":783278670},{"date":"2026-04-17","current":7.668822,"twenty":23.13114,"median":29.705337,"eighty":38.419858,"marketCap":849283708},{"date":"2026-04-24","current":7.92462,"twenty":22.959771,"median":29.615359,"eighty":38.380611,"marketCap":877612050},{"date":"2026-05-01","current":7.326053,"twenty":22.880081,"median":29.470231,"eighty":38.282735,"marketCap":811323729},{"date":"2026-05-08","current":7.617663,"twenty":22.847068,"median":29.327683,"eighty":38.184209,"marketCap":843618039},{"date":"2026-05-15","current":6.415412,"twenty":22.722307,"median":29.206161,"eighty":38.041491,"marketCap":710474829},{"date":"2026-05-22","current":6.338673,"twenty":22.581017,"median":28.928656,"eighty":37.95404,"marketCap":701976327},{"date":"2026-05-29","current":6.701906,"twenty":22.463575,"median":28.85355,"eighty":37.93304,"marketCap":742202573},{"date":"2026-06-05","current":11.066918,"twenty":22.355552,"median":28.723098,"eighty":37.913591,"marketCap":570532817},{"date":"2026-06-12","current":12.045027,"twenty":22.082048,"median":28.568928,"eighty":37.870529,"marketCap":620957267},{"date":"2026-06-18","current":12.056017,"twenty":22.028863,"median":28.441356,"eighty":37.806965,"marketCap":621523834},{"date":"2026-06-26","current":14.440844,"twenty":21.88078,"median":28.164079,"eighty":37.786268,"marketCap":744468840},{"date":"2026-07-02","current":18.69397,"twenty":21.779625,"median":28.062977,"eighty":37.763464,"marketCap":963730211},{"date":"2026-07-10","current":19.045649,"twenty":21.529345,"median":27.910348,"eighty":37.653213,"marketCap":981860351},{"date":"2026-07-17","current":14.619425,"twenty":21.127625,"median":27.658443,"eighty":37.642713,"marketCap":753675212},{"date":"2026-07-24","current":13.894717,"twenty":20.840778,"median":27.290118,"eighty":37.637463,"marketCap":716314323},{"date":"2026-07-31","current":13.102906,"twenty":20.627222,"median":27.097913,"eighty":37.608063,"marketCap":675494093},{"date":"2026-08-07","current":12.096366,"twenty":20.299418,"median":26.927161,"eighty":37.545851,"marketCap":623603970},{"date":"2026-08-14","current":11.926373,"twenty":19.78552,"median":26.9103,"eighty":37.435797,"marketCap":614840304},{"date":"2026-08-21","current":11.192718,"twenty":19.351603,"median":26.903692,"eighty":37.382312,"marketCap":577018170},{"date":"2026-08-28","current":13.411578,"twenty":19.023056,"median":26.740169,"eighty":37.366561,"marketCap":691407064},{"date":"2026-09-04","current":12.642134,"twenty":18.467579,"median":26.645529,"eighty":37.293061,"marketCap":651739948},{"date":"2026-09-09","current":39.634009,"twenty":18.46445,"median":26.645529,"eighty":37.346611,"marketCap":600772315}],"updateTime":1789069519377},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ODD\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2630589138","title":"Creating a Sustainable Impact: Fosun International Releases 2025 ESG Report and Climate Information Disclosures Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2630589138","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630589138?lang=en_us&edition=fundamental","pubTime":"2026-04-28 23:04","pubTimestamp":1777388640,"startTime":"0","endTime":"0","summary":"HONG KONG, April 28, 2026 /PRNewswire/ --Fosun International Limited , together with its subsidiaries , released the Environmental, Social and Governance  Report 2025 . Facing the increasingly severe challenges of global climate change, Fosun released its fourth Climate Information Disclosures Report with reference to Part D  of Appendix C2 \"Environmental, Social and Governance Reporting Code\" of the Main Board Listing Rules of the Hong Kong Stock Exchange, the framework of the Task Force on Climate-Related Financial Disclosures  recommendations and the International Financial Reporting Standards S2 Climate-related Disclosures Requirements .As an industry group rooted in China with a global presence, Fosun always places sustainability at the core of its strategy, responding to the expectations of the times and society through concrete actions. Fosun's sustainable development strategy, \"Create IMPACT\", centers on six long-term strategic directions, which stand for I: Innovation-driven, ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/creating-a-sustainable-impact-fosun-international-releases-2025-esg-report-and-climate-information-disclosures-report-302755896.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BFC","BK4139","BK4183","BK4211","BK7505","ESG","III","BK4201","ICCC","BFC.AU","BK7141","BK7509","IE0009354923.USD","BK4134","ODD","EC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630393335","title":"Intellia Therapeutics Reports Positive Phase 3 Results in Hereditary Angioedema, Marking a Global First for In Vivo Gene Editing","url":"https://stock-news.laohu8.com/highlight/detail?id=2630393335","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630393335?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:00","pubTimestamp":1777287600,"startTime":"0","endTime":"0","summary":"Phase 3 HAELO trial of lonvoguran ziclumeran (lonvo-z) met primary and all key secondary endpoints;favorable safety and tolerability data observed Single dose of lonvo-z freed most patients from both ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/27/3281473/0/en/Intellia-Therapeutics-Reports-Positive-Phase-3-Results-in-Hereditary-Angioedema-Marking-a-Global-First-for-In-Vivo-Gene-Editing.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0034390439.USD","BK4183","LU1861558580.USD","LU1169589451.USD","LU0205194284.USD","BK4198","HAE","LU0106261612.USD","LU0205193047.USD","BK4585","IE00BLDYK493.USD","NTLA","IE0009354923.USD","IE00B64QTZ34.USD","LU1861559042.SGD","BK4556","BK4535","BK4588","BK4139","IE00B19Z6F94.USD","LU1169590202.USD","LU0012050646.USD","ODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629323338","title":"Oddity Tech faces shareholder class action over alleged advertising cost disclosure omissions","url":"https://stock-news.laohu8.com/highlight/detail?id=2629323338","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629323338?lang=en_us&edition=fundamental","pubTime":"2026-04-23 21:02","pubTimestamp":1776949371,"startTime":"0","endTime":"0","summary":"Class action filed on behalf of investors who bought Oddity Tech securities between Feb. 26, 2025 and Feb. 24, 2026.Lawsuit alleges Oddity omitted known disruptions to advertising costs that were eroding its financial model.Complaint cites Item 303 disclosure requirements, alleging filings used generic risk language instead of detailing a specific adverse trend.Oddity shares fell 49.2% to $14.74 on Feb. 25, 2026, a drop of $14.28 per share.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nNDL9cyV4g:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009354923.USD","ODD","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629783311","title":"Radiopharm Theranostics Reports Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2629783311","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629783311?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:00","pubTimestamp":1776942000,"startTime":"0","endTime":"0","summary":"Completed enrolment in Phase 2b clinical trial of imaging agent RAD 101 in patients with recurrent brain metastases following earlier announcement of interim data demonstrating concordance with MRI (t","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/23/3279721/0/en/Radiopharm-Theranostics-Reports-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4128","DSMC","BK4139","BK4213","ODD","IE0009354923.USD","SOC","BK4183","RAD","RADX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629611037","title":"Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Opamtistomig (LBL-024) Enters Phase Ⅱ Trial with First Patient Dosing in Gastric Cancer, Pioneering Enhanced Immunotherapy Combination Strategies","url":"https://stock-news.laohu8.com/highlight/detail?id=2629611037","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629611037?lang=en_us&edition=fundamental","pubTime":"2026-04-21 21:47","pubTimestamp":1776779220,"startTime":"0","endTime":"0","summary":"NANJING, China, April  21, 2026 (GLOBE NEWSWIRE) -- Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,” Stock Code: 9887.HK) today announced that the first patient has been successfully","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/21/3278105/0/en/Leads-Biolabs-PD-L1-4-1BB-Bispecific-Antibody-Opamtistomig-LBL-024-Enters-Phase-Trial-with-First-Patient-Dosing-in-Gastric-Cancer-Pioneering-Enhanced-Immunotherapy-Combination-Stra.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","BK4006","LU2092937221.SGD","LU2360108059.USD","HCC","IE00B3CCJ633.GBP","OC","LU1917777945.USD","ODD","IE00BGHQF417.EUR","CPS","LU2023250843.SGD","LU2048586759.USD","LU2298321311.HKD","BK4195","BTC","LU1974910355.USD","BK4086","IE00B2PGVK34.USD","LU2106854487.HKD","BK4211","BK4124","BK4183","LU2041044095.USD","LU1169589451.USD","LU1169590202.USD","PFS","IE0009354923.USD","LU0868494617.USD","LU2023250504.SGD","PD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628203704","title":"Medicus Pharma submits ODD application to U.S. FDA for SkinJect","url":"https://stock-news.laohu8.com/highlight/detail?id=2628203704","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628203704?lang=en_us&edition=fundamental","pubTime":"2026-04-17 19:35","pubTimestamp":1776425750,"startTime":"0","endTime":"0","summary":"Medicus Pharma (MDCX) announced the submission of an Orphan Drug Designation, ODD, application to the U.S. Food and Drug Administration for SkinJec...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/medicus-pharma-submits-odd-application-to-u-s-fda-for-skinject-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/medicus-pharma-submits-odd-application-to-u-s-fda-for-skinject-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDCX","IE0009354923.USD","BK4139","LABU","BK4588","BK4183","BK4585","ODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628278514","title":"ASX Runners of the Week: Bison, Genetic Signatures, Narryer & Immutep","url":"https://stock-news.laohu8.com/highlight/detail?id=2628278514","media":"The West Australian","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628278514?lang=en_us&edition=fundamental","pubTime":"2026-04-17 06:27","pubTimestamp":1776378463,"startTime":"0","endTime":"0","summary":"The Bulls N’ Bears ASX Runner of the Week is… Bison Resources, which exploded on debut, as punters piled into its prime Nevada gold-silver projects amid ongoing fuel security chaos.","market":"us","thumbnail":"https://images.thewest.com.au/publication/C-22156398/f3ba145e5bde0aa97d4b38a2ae55d7e52f82c4d9.jpg","type":0,"news_type":0,"thumbnails":["https://images.thewest.com.au/publication/C-22156398/f3ba145e5bde0aa97d4b38a2ae55d7e52f82c4d9.jpg"],"rights":{"source":"thewest_stock","url":"https://thewest.com.au/business/bulls-n-bears/asx-runners-of-the-week-bison-genetic-signatures-narryer-immutep-c-22156398","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thewest.com.au/business/bulls-n-bears/asx-runners-of-the-week-bison-genetic-signatures-narryer-immutep-c-22156398","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"thewest_stock","symbols":["GDXD","GOLY","DBC","BK7508","BK7095","BK4183","IAU","RING","DULL","PICK","BSR.AU","DGP","BK7048","AAAU","DUST","GDX","BK7501","GDXJ","BK4588","JNUG","BK7067","BEGS","OUNZ","BK4535","SGOL","NYM.AU","IE0009354923.USD","FGDL","UGL","DZZ","GDXU","GBUG","PHYS","GSS.AU","GLDM","BTGD","IAUI","ODD","GLL","IAUM","GDXY","BAR","BK4585","GLTR","IMM.AU","USG","JDST","XME","CEF","BK7104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627155962","title":"Oddity Tech faces securities class action over alleged misleading ad efficiency disclosures","url":"https://stock-news.laohu8.com/highlight/detail?id=2627155962","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627155962?lang=en_us&edition=fundamental","pubTime":"2026-04-16 21:06","pubTimestamp":1776344776,"startTime":"0","endTime":"0","summary":"Oddity Tech faces securities class action in U.S. District Court for Southern District of New York over alleged misleading disclosures on digital advertising efficiency.Complaint targets purchases of ODD securities from Feb. 26, 2025 to Feb. 24, 2026.Shares fell USD 14.28 to mark a 49.2% drop following Feb. 25, 2026 disclosure of an algorithm change at largest advertising partner.Management projected Q1 2026 revenue decline of about 30% year over year.Lawsuit alleges violations of Exchange Act Sections 10 and 20 tied to customer acquisition costs and sustainability of advertising model.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nNDL4QQ37d:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ODD","BK4183","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626200142","title":"A Look At Oddity Tech (ODD) Valuation As Securities Class Action Raises Questions On Customer Acquisition Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2626200142","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626200142?lang=en_us&edition=fundamental","pubTime":"2026-04-11 11:27","pubTimestamp":1775878071,"startTime":"0","endTime":"0","summary":"Faruqi & Faruqi, LLP has filed a federal securities class action against Oddity Tech (NasdaqGM:ODD). The suit alleges misleading disclosures about customer acquisition costs after an algorithm change by its largest advertising partner prompted a sharp share-price reaction.\nSee our latest analysis for Oddity Tech.\nAt a latest share price of US$14.53, Oddity Tech has seen a 15.82% 1 month share price return and a 4.83% 7 day share price return, but a 63.17% year to date share price decline and...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/5221000-choice1-main-header/1585186890345","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/5221000-choice1-main-header/1585186890345"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/household/nasdaq-odd/oddity-tech/news/a-look-at-oddity-tech-odd-valuation-as-securities-class-acti","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/household/nasdaq-odd/oddity-tech/news/a-look-at-oddity-tech-odd-valuation-as-securities-class-acti","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4183","IE0009354923.USD","ODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626484187","title":"Immix Biopharma to Participate in the Jefferies Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2626484187","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626484187?lang=en_us&edition=fundamental","pubTime":"2026-04-09 20:45","pubTimestamp":1775738700,"startTime":"0","endTime":"0","summary":"LOS ANGELES, CA, April  09, 2026 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), the global leader in relapsed/refractory AL Amyloidosis, today announced tha","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/09/3270986/0/en/Immix-Biopharma-to-Participate-in-the-Jefferies-Global-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128526141.USD","BK4183","BK4585","XBI","XLV","BK4581","HCSG","BK4137","LU0029874061.USD","ODD","BK4588","LABU","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626215188","title":"Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Advances to Expansion Phase in First-Line Biliary Tract Cancer Following Positive Safety and Preliminary Efficacy Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2626215188","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626215188?lang=en_us&edition=fundamental","pubTime":"2026-04-09 16:34","pubTimestamp":1775723640,"startTime":"0","endTime":"0","summary":"NANJING, China, April  09, 2026 (GLOBE NEWSWIRE) -- Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,” Stock Code: 9887.HK) announced that its proprietary PD-L1/4-1BB bispecific antibo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/09/3270693/0/en/Leads-Biolabs-Opamtistomig-PD-L1-4-1BB-Bispecific-Antibody-Advances-to-Expansion-Phase-in-First-Line-Biliary-Tract-Cancer-Following-Positive-Safety-and-Preliminary-Efficacy-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","BTC","LU2298321311.HKD","LU1917777945.USD","ORR","BK4183","ODD","IE00B3CCJ633.GBP","LU0868494617.USD","LU1974910355.USD","LU2023250843.SGD","OC","LU1169590202.USD","BK4006","LU2106854487.HKD","IE0009354923.USD","LU2041044095.USD","LU2092937221.SGD","LU2048586759.USD","LU1169589451.USD","HCC","PD","LU2023250504.SGD","LU2360108059.USD","IE00B2PGVK34.USD","BK4086","IE00BGHQF417.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625949165","title":"Plus Therapeutics Granted U.S. FDA Orphan Drug Designation to REYOBIQ™ in Pediatric Malignant Gliomas","url":"https://stock-news.laohu8.com/highlight/detail?id=2625949165","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625949165?lang=en_us&edition=fundamental","pubTime":"2026-04-08 19:30","pubTimestamp":1775647800,"startTime":"0","endTime":"0","summary":"HOUSTON, April  08, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq:PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/08/3270005/0/en/Plus-Therapeutics-Granted-U-S-FDA-Orphan-Drug-Designation-to-REYOBIQ-in-Pediatric-Malignant-Gliomas.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSF","LENZ","NCI","ODD","BK4135","LABU","BK4183","BK4202","IND","CNS","BK4585","BK4588","BK4539","BK4007","BK4139","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625966700","title":"Kodiak AI Expands Autonomous Trucking Beyond the Sunbelt with Demonstrations in Ohio and Indiana","url":"https://stock-news.laohu8.com/highlight/detail?id=2625966700","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625966700?lang=en_us&edition=fundamental","pubTime":"2026-04-08 04:30","pubTimestamp":1775593800,"startTime":"0","endTime":"0","summary":"Milestone program with DriveOhio’s Ohio Truck Automation Project marks Kodiak’s operational expansion outside of the Sunbelt, showcases how driverless trucks can transform critical Northern freight corridors","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/07/3269653/0/en/Kodiak-AI-Expands-Autonomous-Trucking-Beyond-the-Sunbelt-with-Demonstrations-in-Ohio-and-Indiana.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4528","CHAT","ARTY","AIYY","TRC","AIPO","ODOT","BK4023","AGIX","IE0009354923.USD","BK4193","BK4543","AI","BK4183","BK4587","BK4551","BK4588","ODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625963898","title":"Oddity Tech (ODD) Faces Investor Lawsuit Over Alleged Ad Algorithm Disclosures","url":"https://stock-news.laohu8.com/highlight/detail?id=2625963898","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625963898?lang=en_us&edition=fundamental","pubTime":"2026-04-08 02:46","pubTimestamp":1775587599,"startTime":"0","endTime":"0","summary":"Oddity Tech (ODD) told investors its AI-powered beauty platform was thriving. Growth was strong. Guidance kept rising. But behind the scenes, an al...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/class-action/oddity-tech-odd-faces-investor-lawsuit-over-alleged-ad-algorithm-disclosures?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/class-action/oddity-tech-odd-faces-investor-lawsuit-over-alleged-ad-algorithm-disclosures?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4551","AI","BK4528","ODD","BK4587","BK4588","IE0009354923.USD","AIYY","BK4023","AGIX","BK4183","ARTY","BK4543","CHAT","AIPO","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623343315","title":"Immix Biopharma Announces Enrollment Completion of BLA-Enabling Relapsed/Refractory AL Amyloidosis Trial NEXICART-2, and Upcoming Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2623343315","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623343315?lang=en_us&edition=fundamental","pubTime":"2026-03-30 20:45","pubTimestamp":1774874700,"startTime":"0","endTime":"0","summary":"– Full enrollment of BLA-enabling trial complete, per prior guidance –– Topline NEXICART-2 Results Expected Q3 2026, followed by BLA submission and planned commercial launch –– Onboarded Chief Medical","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/30/3264634/0/en/Immix-Biopharma-Announces-Enrollment-Completion-of-BLA-Enabling-Relapsed-Refractory-AL-Amyloidosis-Trial-NEXICART-2-and-Upcoming-Milestones.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AL","CAR","BK4183","IE0034390439.USD","BK4585","LU1169589451.USD","BK4572","BK4022","IE00B19Z6F94.USD","LABU","IE0009354923.USD","LU1169590202.USD","BK4588","BK4104","ODD","BK4230"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623311997","title":"Press Release: Unicycive Therapeutics Announces Full Year 2025 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2623311997","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623311997?lang=en_us&edition=fundamental","pubTime":"2026-03-30 19:05","pubTimestamp":1774868700,"startTime":"0","endTime":"0","summary":"under review by U.S. Food and Drug Administration  with a. Prescription Drug User Fee Act  target action date of June 29,-- Commercial readiness activities ongoing in anticipation of potential. securities totaled $54.9 million, with expected runway into 2027. \"This year is shaping up to be pivotal for Unicycive, underscored by the U.S. Food and Drug Administration's acceptance of our New Drug Application resubmission for OLC and the potential for approval and launch later this year,\" said Shalabh Gupta, M.D., Chief Executive Officer of Unicycive. \"With hyperphosphatemia still uncontrolled in nearly 75% of U.S. patients with chronic kidney disease undergoing dialysis, OLC, if approved, has the potential to offer a meaningful new treatment option characterized by a differentiated clinical profile and reduced pill burden compared to currently available phosphate binders.\". resubmission of its NDA for OLC, an investigational oral phosphate binder. launch of OLC later this year, the Company","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443549.SGD","LU2237443895.HKD","BK4588","IE00BFXG1179.USD","ODD","IE00BZ1G4Q59.USD","LU0267386448.USD","BK4183","IE00BHPRN162.USD","LU0170899867.USD","BK4139","LU0971096721.USD","LU2237443622.USD","LU0882574139.USD","IE00BKVL7J92.USD","LU1363072403.SGD","LU2237443465.HKD","LU2237443978.SGD","LU2746668461.USD","LU2746668974.SGD","CMC","LU0149725797.USD","IE00B1BXHZ80.USD","LABU","UNCY","BK4006","BK4585","BK4539","LU2237443382.USD","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622874140","title":"ODDITY Tech Is Maintained at Neutral by Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2622874140","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622874140?lang=en_us&edition=fundamental","pubTime":"2026-03-28 01:36","pubTimestamp":1774632960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ODD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 27, 2026 13:36 ET (17:36 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622009503","title":"Oddity Tech Faces Securities Lawsuit After Stock Drops Nearly 50% on Advertising Disruption Disclosure","url":"https://stock-news.laohu8.com/highlight/detail?id=2622009503","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622009503?lang=en_us&edition=fundamental","pubTime":"2026-03-26 02:08","pubTimestamp":1774462113,"startTime":"0","endTime":"0","summary":"Oddity Tech (ODD) told investors its AI-driven beauty platform was delivering strong growth and profitability. But behind the scenes, something was...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/class-action/oddity-tech-faces-securities-lawsuit-after-stock-drops-nearly-50-on-advertising-disruption-disclosure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/class-action/oddity-tech-faces-securities-lawsuit-after-stock-drops-nearly-50-on-advertising-disruption-disclosure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4587","BK4588","BK4528","AIPO","AGIX","BK4183","IE0009354923.USD","AIYY","CHAT","BK4551","BK4543","BK4585","BK4023","ODD","AI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622013950","title":"Oddity Tech director Michael Farello files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2622013950","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622013950?lang=en_us&edition=fundamental","pubTime":"2026-03-25 04:27","pubTimestamp":1774384050,"startTime":"0","endTime":"0","summary":"Oddity director Michael Farello filed an initial Form 3 reporting direct ownership of 57,143 Class A ordinary shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oddity Tech Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 24, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nNDLQkVpJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","IE0009354923.USD","ODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167521893","title":"Key Corporate Announcements Summary for March 24 Evening","url":"https://stock-news.laohu8.com/highlight/detail?id=1167521893","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167521893?lang=en_us&edition=fundamental","pubTime":"2026-03-24 19:31","pubTimestamp":1774351864,"startTime":"0","endTime":"0","summary":"Jiuzhitong announced that its invested company, GALAXIS TECH Group Co., Ltd., was listed on the Main Board of the Hong Kong Stock Exchange on March 24. The company's investment cost was 26.6 million...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02729","BK4183","IE0009354923.USD","PID","ODD"],"isVideo":false,"video":null,"gpt_icon":1}],"pageSize":20,"totalPage":8,"pageCount":7,"totalSize":152,"code":"91000000","status":"200"}]}}